Download Pill Peddlers full books in PDF, epub, and Kindle. Read online free Pill Peddlers ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Jonathan Liebenau |
| Publisher | : |
| Total Pages | : 148 |
| Release | : 1990 |
| Genre | : Drug trade |
| ISBN | : |
Papers cover the history of the pharmaceutical industry and of pharmacists and industralists in Great Britain, Switzerland, France, and America.
| Author | : Michael Levi |
| Publisher | : Routledge |
| Total Pages | : 361 |
| Release | : 2005-07-15 |
| Genre | : Business & Economics |
| ISBN | : 1134294247 |
The phenomenon of psycho-active drugs, and our reactions to them, is one of the most fascinating topics of the social history of mankind. Starting with an analysis of the 'policy of fear' in which law enforcement is 'haunted' by drug money, Drugs and Money offers a radical reconsideration of this highly contentious issue. In this intriguing book, Petrus C. van Duyne and Michael Levi expose an ever-unfolding series of problems: the proliferation of mind-influencing substances the complications of international drug regulation the interaction between markets and economic actors, with the consequent amassing of huge amounts of crime-money. The social, cultural and economic aspects of this crime-money are explored, alongside the ongoing threat it poses to the legitimate economy and the state.
| Author | : Dominique A. Tobbell |
| Publisher | : Univ of California Press |
| Total Pages | : 310 |
| Release | : 2012 |
| Genre | : Business & Economics |
| ISBN | : 0520271130 |
"Tobbell analyzes the political and economic history of the alignment of the pharmaceutical industry, academic institutions and their faculty and organized medicine. This book is essential reading for policymakers and their staff as well as persons who study the history of health policy and those who contribute to it through medical research, advocacy and journalism. " -Daniel Fox, author of The Convergence of Science and Governance: Research, Health Policy, and American States "Dominique Tobbell’s vivid, balanced and probing account of pharmaceutical politics is a significant, needed analysis of the relationships between the pharmaceutical industry, university researchers, the medical profession and government in the Cold War period. More than this, Pills, Power, and Policy shows why it continues to be difficult to agree in the United States on the relative roles of corporate enterprise, government regulation, technological innovation, freedom to prescribe, and consumer marketing and protection, all played out against the rising costs of health care. Timely and thought-provoking."--Rosemary A. Stevens. DeWitt Wallace Distinguished Scholar, Department of Psychiatry, Weill Cornell Medical College "A superb and compelling account of the creation of one of America’s most reviled entities: Big Pharma. With clarity and subtlety, Pills, Power, and Policy weaves together the political, economic, and the medical to reveal the entangled history behind our modern pharmaceutical predicament."--Andrea Tone, Ph.D., Professor of History & Canada Research Chair in the Social History of Medicine, McGill University “Pills, Power and Policy provides an outstanding description and analysis of the evolution of drug policy. It is an extremely important contribution to our understanding of the political, scientific, and economic nature of pharmaceutical regulation." -Daniel S. Greenberg, Washington journalist and author of Science, Money and Politics: Political Triumph and Ethical Erosion
| Author | : Virginia Berridge |
| Publisher | : Routledge |
| Total Pages | : 321 |
| Release | : 2004-08-02 |
| Genre | : Health & Fitness |
| ISBN | : 1134408560 |
This collection opens up the post war history of public health to sustained research-based historical scrutiny. Medicine, the Market and the Mass Media examines the development of a new view of 'the health of the public' and the influences which shaped it in the post war years. Taking a broad perspective the book examines developments in Western Europe, and the relationships between Europe and the US. The essays looks at the dual legacy of social medicine through health services and health promotion, and analyse the role of mass media along with the connections between public health and industry. This international collection will appeal to public health professionals, students of the history of medicince and of heath policy
| Author | : Helen J. Power |
| Publisher | : Routledge |
| Total Pages | : 315 |
| Release | : 2012-11-12 |
| Genre | : History |
| ISBN | : 1136174079 |
First published in 1998. Despite the upsurge of interest in the history of tropical medicine, international public health and the provision of health care in colonial and post-colonial tropical countries, no major text discusses the history of the academic discipline in the twentieth century. In Britain, the two Schools of Tropical Medicine opened within six months of each other in the final year of the nineteenth century. They have played a pivotal role in developing tropical medicine, as an academic discipline in postgraduate medicine with an active research profile. The Schools also affected the development of health care in the tropical colonies. They trained the Medical Officers of the Colonial Medical Service and the indigenous doctors whose training failed to include infectious endemic diseases and lacked an emphasis on community health. The Schools also contributed to a body of knowledge applied by the colonial powers, international agencies and independent nation states as part of their health care programmes. Ultimately the Schools helped the developing world to establish its own priorities for health. This volume charts the history of the Liverpool School of Tropical Medicine from1898 to1990.
| Author | : Soraya de Chadarevian |
| Publisher | : Taylor & Francis |
| Total Pages | : 313 |
| Release | : 2003-09-02 |
| Genre | : History |
| ISBN | : 1135298017 |
The contributors present a coherent set of case studies of practices, technologies and strategies aimed at the isolation, investigation, manipulation, production, and uses of molecules including vitamins, hormones, blood products, antibiotics, and vaccines. These case studies examine how processes of molecularization were set in motion in the inter-war period, how they were used as a resource in the biomedical 'mobilization' of World War II, and how new alliances and strategies created as part of the war effort played a central role in the reorganisation of biomedicine in the post-war period.
| Author | : National Library of Medicine (U.S.) |
| Publisher | : |
| Total Pages | : 1032 |
| Release | : 1990 |
| Genre | : Medicine |
| ISBN | : |
| Author | : |
| Publisher | : |
| Total Pages | : 1308 |
| Release | : 1993 |
| Genre | : Medicine |
| ISBN | : |
| Author | : Melody Petersen |
| Publisher | : Sarah Crichton Books |
| Total Pages | : 448 |
| Release | : 2010-07-01 |
| Genre | : Business & Economics |
| ISBN | : 142994403X |
In the last thirty years, the big pharmaceutical companies have transformed themselves into marketing machines selling dangerous medicines as if they were Coca-Cola or Cadillacs. They pitch drugs with video games and soft cuddly toys for children; promote them in churches and subways, at NASCAR races and state fairs. They've become experts at promoting fear of disease, just so they can sell us hope. No question: drugs can save lives. But the relentless marketing that has enriched corporate executives and sent stock prices soaring has come with a dark side. Prescription pills taken as directed by physicians are estimated to kill one American every five minutes. And that figure doesn't reflect the damage done as the overmedicated take to the roads. Our Daily Meds connects the dots for the first time to show how corporate salesmanship has triumphed over science inside the biggest pharmaceutical companies and, in turn, how this promotion driven industry has taken over the practice of medicine and is changing American life. It is an ageless story of the battle between good and evil, with potentially life-changing consequences for everyone, not just the 65 percent of Americans who unscrew a prescription cap every day. An industry with the promise to help so many is now leaving a legacy of needless harm.
| Author | : John E. Lesch |
| Publisher | : |
| Total Pages | : 377 |
| Release | : 2007 |
| Genre | : Medical |
| ISBN | : 019518775X |
In the decade from 1935-1945, while the Second World War raged in Europe, a new class of medicines capable of controlling bacterial infections launched a therapeutic revolution that continues today. The new medicines were not penicillin and antibiotics, but sulfonamides, or sulfa drugs. The sulfa drugs preceded penicillin by almost a decade, and during World War II they carried the main therapeutic burden in both military and civilian medicine. Their success stimulated a rapid expansion of research and production in the international pharmaceutical industry, raised expectations of medicine, and accelerated the appearance of new and powerful medicines based on research. The latter development created new regulatory dilemmas and unanticipated therapeutic problems. The sulfa drugs also proved extraordinarily fruitful as starting points for new drugs or classes of drugs, both for bacterial infections and for a number of important non-infectious diseases. This book examines this breakthrough in medicine, pharmacy, and science in three parts. Part I shows that an industrial research setting was crucial to the success of the revolution in therapeutics that emerged from medicinal chemistry. Part II shows how national differences shaped the reception of the sulfa drugs in Germany, France, Britain, and the United States. The author uses press coverage of the day to explore popular perceptions of the dramatic changes taking place in medicine. Part III documents the impact of the sulfa drugs on the American effort in World War II. It also shows how researchers came to an understanding of how the sulfa drugs worked, adding a new theoretical dimension to the science of pharmacology and at the same time providing a basis for the discovery of new medicinal drugs in the 1940s, 1950s, and 1960s. A concluding chapter summarizes the transforming impact of the sulfa drugs on twentieth-century medicine, tracing the therapeutic revolution from the initial breakthrough in the 1930s to the current search for effective treatments for AIDS and the new horizons opened up by the human genome project and stem cell research.
